Tag Archives: Drug Pricing

Government to Limit Drap Powers and Form New Drug Pricing Body

Regulatory Overhaul The Pakistani government has decided in principle to limit the powers of the Drug Regulatory Authority of Pakistan (Drap) and establish a new, independent body specifically tasked with overseeing the pricing of life-saving drugs. This move aims to address ongoing issues with drug shortages and pricing efficiency. Industry Reaction The Pakistan Pharmaceutical Manufacturers’ Association (PPMA) has welcomed the …

Read More »